Cervical Squamous Intraepithelial Neoplasia 3

• Cervical Squamous Intraepithelial Neoplasia 3 (CIN3) is a high-grade precancerous lesion of the cervix, indicating severe abnormal cell changes.
• It is often referred to as a high-grade squamous intraepithelial lesion (HSIL).
• The primary cause of CIN3 is persistent infection with high-risk types of Human Papillomavirus (HPV).
• CIN3 typically presents with no noticeable symptoms, making regular cervical cancer screening (Pap tests and HPV tests) vital for detection.
• Treatment options, such as LEEP or conization, aim to remove the affected tissue and prevent progression to invasive cancer.

What is Cervical Squamous Intraepithelial Neoplasia 3 (CIN3)?

Cervical Squamous Intraepithelial Neoplasia 3 (CIN3) is the most severe form of precancerous changes found in the cells lining the cervix. It signifies that abnormal cells are present throughout the full thickness of the cervical surface epithelium, but they have not yet invaded deeper tissues. This condition is also commonly referred to as a high-grade squamous intraepithelial lesion (HSIL), a term often used in pathology reports to describe the severity of the cellular abnormalities. Understanding what CIN3 is involves recognizing it as a critical stage where intervention can effectively prevent the development of invasive cervical cancer. According to the World Health Organization (WHO), persistent infection with high-risk Human Papillomavirus (HPV) is the primary cause of nearly all cervical cancers and their precancerous precursors like CIN3.

The classification of CIN (Cervical Intraepithelial Neoplasia) ranges from CIN1 (mild dysplasia), CIN2 (moderate dysplasia), to CIN3 (severe dysplasia or carcinoma in situ). CIN3 is considered a high-grade lesion because it carries a substantial risk of progressing to invasive cancer if left untreated. Regular cervical screening tests, such as the Pap test and HPV test, are essential for detecting these cellular changes early, often before they cause any symptoms. When abnormal cells are identified, further diagnostic procedures like colposcopy and biopsy are performed to confirm the diagnosis and determine the grade of the lesion.

Symptoms and Causes of High-Grade Squamous Intraepithelial Lesion (HSIL)

When discussing CIN3 symptoms and causes, it’s important to note that CIN3, or high-grade squamous intraepithelial lesion, typically does not cause any noticeable symptoms. This asymptomatic nature underscores the importance of routine cervical cancer screening. Women with CIN3 usually feel perfectly healthy, which is why detection often occurs during a routine Pap test or HPV test. If symptoms do occur, they are usually non-specific and may include abnormal vaginal bleeding (e.g., after intercourse, between periods, or post-menopause), unusual vaginal discharge, or pelvic pain. However, these symptoms are more commonly associated with other conditions, including more advanced cervical cancer, rather than CIN3 itself.

The overwhelming cause of CIN3 is persistent infection with high-risk types of the Human Papillomavirus (HPV). HPV is a very common sexually transmitted infection. While most HPV infections clear on their own, persistent infection with certain high-risk types (such as HPV 16 and 18) can lead to cellular changes in the cervix over time. Risk factors that increase the likelihood of developing CIN3 after HPV infection include:

• Early age at first sexual intercourse.
• Multiple sexual partners.
• A weakened immune system (e.g., due to HIV infection or immunosuppressant medications).
• Smoking, which can hinder the body’s ability to clear HPV infections.
• Long-term use of oral contraceptives.
• Other sexually transmitted infections.

It’s crucial to understand that having HPV does not automatically mean a person will develop CIN3 or cervical cancer. However, persistent infection with high-risk HPV types is a necessary precursor for nearly all cases of CIN3 and subsequent cervical cancer.

CIN3 Treatment Options

Effective CIN3 treatment options are available to remove the abnormal cells and prevent progression to invasive cancer. The primary goal of treatment is to remove all affected cervical tissue while preserving as much healthy tissue as possible, especially for women who wish to maintain fertility. The choice of treatment depends on several factors, including the size and location of the lesion, the woman’s age, and her desire for future pregnancies. The most common and effective treatments for CIN3 involve excisional procedures:

• Loop Electrosurgical Excision Procedure (LEEP): This is the most frequently performed procedure. A thin wire loop, heated by an electric current, is used to remove the abnormal tissue from the cervix. LEEP is typically performed in an outpatient setting under local anesthesia.
• Cold Knife Conization: Also known as cone biopsy, this procedure uses a surgical scalpel or laser to remove a cone-shaped piece of tissue from the cervix. It is often performed under general anesthesia and may be preferred for larger lesions, if the lesion extends into the endocervical canal, or if LEEP is not suitable.

Both LEEP and cold knife conization are highly effective in treating CIN3, with success rates often exceeding 90%. After treatment, regular follow-up is essential to ensure that all abnormal cells have been removed and to monitor for any recurrence. This typically involves repeat Pap tests, HPV tests, and sometimes colposcopy. Vaccination against HPV is also recommended for eligible individuals, even after treatment for CIN3, to help prevent future infections with other HPV types and reduce the risk of recurrence, as advised by the Centers for Disease Control and Prevention (CDC).